Author:
Fang Ru,He Liang,Wang Yanbin,Wang Liling,Qian Hua,Yang Shaozong
Funder
Zhejiang Province Public Welfare Technology Application Research Project
Zhejiang Provincial Science and Technology Project
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Park CR, Song MG, Park JY, Youn H, Chung JK, Jeong JM, Lee YS, Cheon GJ, Kan KW (2020) Conjugation of arginylglycylaspartic acid to human serum albumin decreases the tumor-targeting effect of albumin by hindering its secreted protein acidic and rich in cysteine-mediated accumulation in tumors. Am J Transl Res 12(6):2488–2498
2. Park CR, Kim HY, Song MG, Lee YS, Kang KW (2020) Efficacy and safety of human serum albumin–cisplatin complex in U87MG xenograft mouse models. Int J Mol Sci 21(21):7932. https://doi.org/10.3390/ijms21217932
3. Park CR, Jo JH, Song MG, Park MG, Kkang KW (2019) Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models. Theranostics 9(24):7447–7457. https://doi.org/10.7150/thno.34883
4. Alexander MR, Ambre JJ, Liskow BI, Trost DC (1979) Therapeutic use of albumin. JAMA 241(23):2527–2529. https://doi.org/10.1097/00132586-198004000-00018
5. Zhang Y, Zhang H, Wang J, Liu C, Xing HL, Jiang YH, Li XS (2023) Reduction-responsive docetaxel prodrug encapsulated within human serum albumin nanoparticles for cancer therapy. Mol Pharmaceut 20(5):2513–2526. https://doi.org/10.1021/acs.molpharmaceut.2c01107